About US
Contact us
-
Levin lays out 4-year plan to turn Teva into a brandTeva Pharmaceuticals ($TEVA) has money in the bank, drugs in the pipeline and big plans for the future. Given those assets and four more years, CEO Jeremy Levin told investors on Tuesday they will ha2012/12/12
-
Pharmaceutical regulatory affairs teams continue to increase budgetsPharmaceutical companies have continued to boost the budgets allocated to their regulatory affairs teams, despite making overall spending cuts, a study suggests. Cutting Edge Information's latest stu2012/12/11
-
Merck wins back $500K in retaliation lawsuitThe courts giveth and the courts taketh away, and how you view those actions depends on which side of a lawsuit you sit on. In a recent ruling by a federal appeals court, Merck & Co. ($MRK) was ha2012/12/11
-
Endo revises pain drug recall from 1 to 101 lotsIn September, the generics subsidiary of Endo Health Solutions ($ENDP) voluntarily recalled one lot of two pain drugs that it called "super potent" because both exceeded their prescribed weights. Now2012/12/10
-
NICE snubs Pfizer's Inlyta kidney cancer drugPfizer ($PFE) has run into the U.K. watchdog wall of resistance to targeted cancer drugs with its renal cancer treatment Inlyta. The drugmaker was seeking approval for use in patients with advance2012/12/10
-
Another pharma free speech case hits U.S. appeals courtWhile we're still digesting the news that one U.S. appeals court figures off-label discussions are protected by the First Amendment, another panel is considering a similar argument. The Ninth Circuit2012/12/7
-
U.S. patient sues Ranbaxy over generic Lipitor recallLast month, Ranbaxy Laboratories recalled its version of the cholesterol-fighting pill Lipitor. By last week, the company had stopped making the drug, at least until it can iron out the manufacturing2012/12/7
-
Indian bureaucrats decide to review all foreign pharma investmentsAfter months of bureaucratic debate, the Indian government has decided to require government approval of all foreign investment in domestic pharma companies. The Foreign Investment Promotion Board wi2012/12/6
-
Sartorius Stedim Biotech Launches Sartoguard NF Prefilter SeriesSartorius Stedim Biotech (SSB), a leading international pharma supplier, has launched the Sartoguard NF prefilter series, completing its range of Sartoguard prefilters. These new prefilters feature a2012/12/6
-
Should FDA usher old-style opioid generics onto the market?On one side stand Endo Health Solutions ($ENDP) and Purdue Pharma. On the other, generic drugmakers that want to introduce copies of big-selling, high-powered painkillers. In the middle, the FDA, whi2012/12/5